Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EPINIR-BRONCHIO : Evaluation Pragmatique de l'Impact du NIrsevimab Sur le Recours Aux uRgences Pour BRONCHIOlite Evaluation in Practice of the Impact of NIrsevimab on EmeRgency Use for BRONCHIOlitis

NCT06185647 is registered in ClinicalTrials.gov with Hôpital Armand Trousseau as lead sponsor.

NCT NCT06185647
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06185647 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EPINIR-BRONCHIO : Evaluation Pragmatique de l'Impact du NIrsevimab Sur le Recours Aux uRgences Pour BRONCHIOlite Evaluation in Practice of the Impact of NIrsevimab on EmeRgency Use for BRONCHIOlitis
Lead sponsor
Hôpital Armand Trousseau
Phase
Observational
Overall status
Completed
Start date
October 14, 2023
Completion date
February 29, 2024
Enrollment
4,924 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bronchiolitis, immunization; infection, respiratory syncytial virus (rsv)